SIRDALUD cpr 4 mg 30 pce
7680446910359
CH-44691
M03BX02
01.12.0.
1 / 2
google
Details
- Product number
- 4469102
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- tizanidinum 4 mg ut tizanidini hydrochloridum, lactosum 110 mg, cellulosum microcristallinum, acidum stearicum, silica colloidalis anhydrica, pro compresso.
Articles (1)
Sirdalud 4 mg, Tabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
4.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
110.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 19.00
Specialties list
Yes
Generic
No
SL addition date:
15/03/1992
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 44691
- Drug name
- Sirdalud, Tabletten
- Galenic form
- TAB
- ATC Code
- M03BX02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 19/12/1983
- Authorization expiration date
- 31/12/9999
- IT number
- 01.12.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SIRDALUD cpr 4 mg 30 pce
- Description (DE)
- SIRDALUD Tabl 4 mg 30 Stk
- Market launch
- 19/12/1983
- Narcotic (BTM)
- No